United Health Products Inc
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care provider… Read more
United Health Products Inc (UEEC) - Net Assets
Latest net assets as of December 2024: $-2.44 Million USD
Based on the latest financial reports, United Health Products Inc (UEEC) has net assets worth $-2.44 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($269.98K) and total liabilities ($2.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.44 Million |
| % of Total Assets | -905.19% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1248.41 |
United Health Products Inc - Net Assets Trend (2006–2024)
This chart illustrates how United Health Products Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for United Health Products Inc (2006–2024)
The table below shows the annual net assets of United Health Products Inc from 2006 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-2.44 Million | -42.56% |
| 2023-12-31 | $-1.71 Million | +16.98% |
| 2022-12-31 | $-2.06 Million | -80.83% |
| 2021-12-31 | $-1.14 Million | -19.79% |
| 2020-12-31 | $-953.26K | -5.47% |
| 2019-12-31 | $-903.80K | -156.25% |
| 2018-12-31 | $-352.70K | -35.00% |
| 2017-12-31 | $-261.26K | +65.26% |
| 2016-12-31 | $-751.97K | +6.01% |
| 2015-12-31 | $-800.07K | +50.29% |
| 2014-12-31 | $-1.61 Million | -43.47% |
| 2013-12-31 | $-1.12 Million | +26.41% |
| 2012-12-31 | $-1.52 Million | -0.03% |
| 2011-12-31 | $-1.52 Million | -202.31% |
| 2010-12-31 | $-504.11K | -1120.58% |
| 2009-12-31 | $49.40K | +1376.24% |
| 2008-12-31 | $3.35K | +101.16% |
| 2007-12-31 | $-288.99K | -375.90% |
| 2006-12-31 | $-60.73K | -- |
Equity Component Analysis
This analysis shows how different components contribute to United Health Products Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7867485400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $252.41K | % |
| Other Components | $76.00 Million | % |
| Total Equity | $-2.44 Million | 100.00% |
United Health Products Inc Competitors by Market Cap
The table below lists competitors of United Health Products Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ilika plc
OTCQX:ILIKF
|
$60.29 Million |
|
Ege Profil Ticaret ve Sanayi AS
IS:EGPRO
|
$60.29 Million |
|
Edison Opto Corp
TW:3591
|
$60.29 Million |
|
SunCar Technology Group Inc.
NASDAQ:SDA
|
$60.31 Million |
|
CSP Inc
NASDAQ:CSPI
|
$60.22 Million |
|
iBio, Inc. Common Stock
NASDAQ:IBIO
|
$60.21 Million |
|
North European Oil Royalty Trust
NYSE:NRT
|
$60.20 Million |
|
Helius Medical Technologies Inc Class A
NASDAQ:HSDT
|
$60.18 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in United Health Products Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,714,226 to -2,443,831, a change of -729,605.
- Net loss of 2,001,733 reduced equity.
- New share issuances of 929,579 increased equity.
- Other factors increased equity by 342,549.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.00 Million | -81.91% |
| Share Issuances | $929.58K | +38.04% |
| Other Changes | $342.55K | +14.02% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares United Health Products Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | $0.00 | $0.27 | x |
| 2006-12-31 | $0.00 | $0.27 | x |
| 2007-12-31 | $-0.01 | $0.27 | x |
| 2008-12-31 | $0.00 | $0.27 | x |
| 2009-12-31 | $0.00 | $0.27 | x |
| 2010-12-31 | $-0.01 | $0.27 | x |
| 2012-12-31 | $-0.02 | $0.27 | x |
| 2013-12-31 | $-0.01 | $0.27 | x |
| 2014-12-31 | $-0.02 | $0.27 | x |
| 2015-12-31 | $-0.01 | $0.27 | x |
| 2016-12-31 | $0.00 | $0.27 | x |
| 2017-12-31 | $0.00 | $0.27 | x |
| 2018-12-31 | $0.00 | $0.27 | x |
| 2019-12-31 | $-0.01 | $0.27 | x |
| 2020-12-31 | $-0.01 | $0.27 | x |
| 2021-12-31 | $-0.01 | $0.27 | x |
| 2022-12-31 | $-0.01 | $0.27 | x |
| 2023-12-31 | $-0.01 | $0.27 | x |
| 2024-12-31 | $-0.01 | $0.27 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently United Health Products Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-532.19%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.31K |
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-185.09K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-199.37K |
| 2008 | -8269.25% | -3378.38% | 0.03x | 78.34x | $-277.02K |
| 2009 | -1842.31% | -3807.08% | 0.04x | 12.99x | $-914.95K |
| 2010 | 0.00% | -4192.21% | 0.18x | 0.00x | $-2.85 Million |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.44 Million |
| 2013 | 0.00% | -36809.35% | 0.04x | 0.00x | $-1.01 Million |
| 2014 | 0.00% | -1318.15% | 3.97x | 0.00x | $-1.98 Million |
| 2015 | 0.00% | -4865.88% | 1.02x | 0.00x | $-2.51 Million |
| 2016 | 0.00% | -221.37% | 1.23x | 0.00x | $-460.54K |
| 2017 | 0.00% | -144.81% | 0.79x | 0.00x | $-908.84K |
| 2018 | 0.00% | -13096.10% | 0.36x | 0.00x | $-5.97 Million |
| 2019 | 0.00% | -134002.33% | 0.05x | 0.00x | $-6.51 Million |
| 2020 | 0.00% | -144316.58% | 0.02x | 0.00x | $-7.02 Million |
| 2021 | 0.00% | -52826159.32% | 0.00x | 0.00x | $-31.05 Million |
| 2022 | 0.00% | -4497.03% | 0.11x | 0.00x | $-1.48 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.45 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.76 Million |
Industry Comparison
This section compares United Health Products Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| United Health Products Inc (UEEC) | $-2.44 Million | 0.00% | N/A | $60.27 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |